Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Weronika Maria Szejniuk"'
Autor:
Weronika Maria Szejniuk, Martin Skovmos Nielsen, Zsuzsanna Takács-Szabó, Jacek Pawlowski, Sahar Sulaiman Al-Saadi, Panagiotis Maidas, Martin Bøgsted, Tine McCulloch, Jens Brøndum Frøkjær, Ursula Gerda Falkmer, Oluf Dimitri Røe
Publikováno v:
Radiation Oncology, Vol 16, Iss 1, Pp 1-11 (2021)
Abstract Background Symptomatic radiation pneumonitis (RP) may be a serious complication after thoracic radiation therapy (RT) for non-small cell lung cancer (NSCLC). This prospective observational study sought to evaluate the utility of a novel radi
Externí odkaz:
https://doaj.org/article/5f0de29358ed411c9a94c7c262df5853
Autor:
Shona Pedersen, Joachim Bavnhøj Hansen, Raluca Georgiana Maltesen, Weronika Maria Szejniuk, Trygve Andreassen, Ursula Falkmer, Søren Risom Kristensen
Publikováno v:
Metabolism Open, Vol 12, Iss , Pp 100127- (2021)
Background: Small cell lung cancer (SCLC) is a malignant disease with poor prognosis. At the time of diagnosis most patients are already in a metastatic stage. Current diagnosis is based on imaging, histopathology, and immunohistochemistry, but no bl
Externí odkaz:
https://doaj.org/article/cadbd60f9cf04966962b7c95f513826b
Autor:
Amber Louw, Vasiliki Panou, Weronika Maria Szejniuk, Christos Meristoudis, Siaw Ming Chai, Chris van Vliet, Y. C. Gary Lee, Ian M. Dick, Tina Firth, Louise Andersen Lynggaard, Azadeh Birbaneh Asghari, Mogens Vyberg, Johnni Hansen, Jenette Creaney, Oluf Dimitri Røe
Publikováno v:
Louw, A, Panou, V, Szejniuk, W M, Meristoudis, C, Chai, S M, van Vliet, C, Lee, Y C G, Dick, I M, Firth, T, Lynggaard, L A, Asghari, A B, Vyberg, M, Hansen, J, Creaney, J & Røe, O D 2022, ' BAP1 Loss by Immunohistochemistry Predicts Improved Survival to First-Line Platinum and Pemetrexed Chemotherapy for Patients With Pleural Mesothelioma : A validation study ', Journal of Thoracic Oncology, vol. 17, no. 7, pp. 921-930 . https://doi.org/10.1016/j.jtho.2022.04.008
INTRODUCTION: Pleural mesothelioma (PM) is an aggressive malignancy with no identified predictive biomarkers. We assessed whether tumor BAP1 status is a predictive biomarker for survival in patients receiving first-line combination platinum and pemet
Publikováno v:
Mughal, H A, Mouritzen, M T, Takacs-Szabó, Z & Szejniuk, W M 2022, ' Treatment of induced oligometastatic disease after partial response to immunochemotherapy in patient with stage IV non-small cell lung cancer and severe toxicity ', BMJ Case Reports, vol. 15, no. 12, e252590 . https://doi.org/10.1136/bcr-2022-252590
Treatment of induced oligometastatic disease after partial response to systemic antineoplastic therapy in non-small cell lung cancer (NSCLC) remains controversial. The introduction of immune checkpoint inhibitors (ICIs) has revolutionised the treatme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::468f514d10dc7174442b3f85928cfb45
https://vbn.aau.dk/da/publications/56fb0225-5d58-4fd2-81b5-c97a7f44ea31
https://vbn.aau.dk/da/publications/56fb0225-5d58-4fd2-81b5-c97a7f44ea31
Autor:
Weronika Maria Szejniuk, Louise Andersen Lynggård, Oluf Dimitri Røe, Christos Meristoudis, Vasiliki Panou
Publikováno v:
Lynggård, L A, Panou, V, Szejniuk, W, Røe, O D & Meristoudis, C 2022, ' Diagnostic capacity of BAP1 and MTAP in cytology from effusions and biopsy in mesothelioma ', Journal of the American Society of Cytopathology, vol. 11, no. 6, pp. 385-393 . https://doi.org/10.1016/j.jasc.2022.07.003
INTRODUCTION: Serous effusion is often the first sign of mesothelioma. Diagnosis based on cytologic material from the effusions remains controversial and complementary biopsy is usually required. However, obtaining representative tissue sample may be
Autor:
Ursula Falkmer, Camilla Holm Pedersen, Raluca Maltesen, Søren Risom Kristensen, Shona Pedersen, Bent Honoré, Weronika Maria Szejniuk, Katrine Papendick Jensen
Publikováno v:
Pedersen, S, Jensen, K P, Honoré, B, Kristensen, S R, Pedersen, C H, Szejniuk, W M, Maltesen, R G & Falkmer, U 2022, ' Circulating microvesicles and exosomes in small cell lung cancer by quantitative proteomics ', Clinical Proteomics, vol. 19, 2 . https://doi.org/10.1186/s12014-021-09339-5
Pedersen, S, Jensen, K P, Honoré, B, Kristensen, S R, Pedersen, C H, Szejniuk, W M, Maltesen, R G & Falkmer, U 2022, ' Circulating microvesicles and exosomes in small cell lung cancer by quantitative proteomics ', Clinical proteomics, vol. 19, no. 1, 2 . https://doi.org/10.1186/s12014-021-09339-5
Pedersen, S, Jensen, K P, Honoré, B, Kristensen, S R, Pedersen, C H, Szejniuk, W M, Maltesen, R G & Falkmer, U 2022, ' Circulating microvesicles and exosomes in small cell lung cancer by quantitative proteomics ', Clinical proteomics, vol. 19, no. 1, 2 . https://doi.org/10.1186/s12014-021-09339-5
Background Early detection of small cell lung cancer (SCLC) crucially demands highly reliable markers. Growing evidence suggests that extracellular vesicles carry tumor cell-specific cargo suitable as protein markers in cancer. Quantitative proteomic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d69eaa762c7e9a207779a5bebabcca4
https://pure.au.dk/portal/da/publications/circulating-microvesicles-and-exosomes-in-small-cell-lung-cancer-by-quantitative-proteomics(da9cdbee-999b-408b-ad79-feda8763141d).html
https://pure.au.dk/portal/da/publications/circulating-microvesicles-and-exosomes-in-small-cell-lung-cancer-by-quantitative-proteomics(da9cdbee-999b-408b-ad79-feda8763141d).html
Autor:
Ulla Møller Weinreich, Martin Bøgsted, Dorthe Scavenius Brønnum, Jesper Carl, Oluf Dimitri Røe, I. Jensen, Tine McCulloch, Ursula Falkmer, Martin Skovmos Nielsen, Weronika Maria Szejniuk, Zsuzsanna Takacs-Szabó, L. Pilegaard Thomsen
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 19, Iss, Pp 103-109 (2019)
Szejniuk, W M, Nielsen, M S, Brønnum, D, Takács-Szabó, Z, Weinreich, U M, Thomsen, L P, Bøgsted, M, Jensen, I, McCulloch, T, Falkmer, U G, Carl, J & Røe, O D 2019, ' Fractional exhaled nitric oxide as a potential biomarker for radiation pneumonitis in patients with non-small cell lung cancer : A pilot study ', Clinical and translational radiation oncology, vol. 19, pp. 103-109 . https://doi.org/10.1016/j.ctro.2019.09.004
Clinical and Translational Radiation Oncology
Szejniuk, W M, Nielsen, M S, Brønnum, D, Takács-Szabó, Z, Weinreich, U M, Thomsen, L P, Bøgsted, M, Jensen, I, McCulloch, T, Falkmer, U G, Carl, J & Røe, O D 2019, ' Fractional exhaled nitric oxide as a potential biomarker for radiation pneumonitis in patients with non-small cell lung cancer : A pilot study ', Clinical and translational radiation oncology, vol. 19, pp. 103-109 . https://doi.org/10.1016/j.ctro.2019.09.004
Clinical and Translational Radiation Oncology
Highlights • Weekly measurements of fractional exhaled nitric oxide during radiation therapy for non-small cell lung cancer can be useful in predicting radiation pneumonitis. • One year of regular clinical follow-up is necessary for patients trea
Autor:
Joachim Bavnhøj Hansen, Trygve Andreassen, Søren Risom Kristensen, Shona Pedersen, Weronika Maria Szejniuk, Ursula Falkmer, Raluca Maltesen
Publikováno v:
Pedersen, S, Hansen, J B, Maltesen, R G, Szejniuk, W M, Andreassen, T, Falkmer, U G I & Kristensen, S R 2021, ' Identifying metabolic alterations in newly diagnosed small cell lung cancer patients ', Metabolism Open, vol. 12, 100127 . https://doi.org/10.1016/j.metop.2021.100127
Metabolism Open
Metabolism Open, Vol 12, Iss, Pp 100127-(2021)
Metabolism Open
Metabolism Open, Vol 12, Iss, Pp 100127-(2021)
Background: Small cell lung cancer (SCLC) is a malignant disease with poor prognosis. At the time of diagnosis most patients are already in a metastatic stage. Current diagnosis is based on imaging, histopathology, and immunohistochemistry, but no bl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f691d35e6950efd460271289675ddd88
https://vbn.aau.dk/ws/files/446147984/1_s2.0_S2589936821000517.pdf
https://vbn.aau.dk/ws/files/446147984/1_s2.0_S2589936821000517.pdf
Autor:
Zsuzsanna Takacs-Szabó, Panagiotis Maidas, Sahar Sulaiman Al-Saadi, Jens Brøndum Frøkjær, Martin Bøgsted, Oluf Dimitri Røe, Ursula Falkmer, Martin Skovmos Nielsen, Tine McCulloch, Jacek Pawlowski, Weronika Maria Szejniuk
Publikováno v:
Radiation Oncology, Vol 16, Iss 1, Pp 1-11 (2021)
Radiation Oncology (London, England)
Szejniuk, W M, Nielsen, M S, Takács-Szabó, Z, Pawlowski, J, Al-Saadi, S S, Maidas, P, Bøgsted, M, McCulloch, T, Frøkjær, J B, Falkmer, U G & Røe, O D 2021, ' High-dose thoracic radiation therapy for non-small cell lung cancer : a novel grading scale of radiation-induced lung injury for symptomatic radiation pneumonitis ', Radiation Oncology, vol. 16, no. 1, 131 . https://doi.org/10.1186/s13014-021-01857-8
Radiation Oncology
Radiation Oncology (London, England)
Szejniuk, W M, Nielsen, M S, Takács-Szabó, Z, Pawlowski, J, Al-Saadi, S S, Maidas, P, Bøgsted, M, McCulloch, T, Frøkjær, J B, Falkmer, U G & Røe, O D 2021, ' High-dose thoracic radiation therapy for non-small cell lung cancer : a novel grading scale of radiation-induced lung injury for symptomatic radiation pneumonitis ', Radiation Oncology, vol. 16, no. 1, 131 . https://doi.org/10.1186/s13014-021-01857-8
Radiation Oncology
Background Symptomatic radiation pneumonitis (RP) may be a serious complication after thoracic radiation therapy (RT) for non-small cell lung cancer (NSCLC). This prospective observational study sought to evaluate the utility of a novel radiation-ind
Autor:
Weronika Maria Szejniuk, Martin Bøgsted, Christos Meristoudis, Tine McCulloch, M Cekala, Oluf Dimitri Røe, Ursula Falkmer
Publikováno v:
Cancer Treatment and Research Communications, Vol 27, Iss, Pp 100318-(2021)
Szejniuk, W M, Cekala, M, Bøgsted, M, Meristoudis, C, McCulloch, T, Falkmer, U G & Røe, O D 2021, ' Adjuvant platinum-based chemotherapy in non-small cell lung cancer : The role of relative dose-intensity and treatment delay ', Cancer Treatment and Research Communications, vol. 27, 100318 . https://doi.org/10.1016/j.ctarc.2021.100318
Cancer Treatment and Research Communications
Szejniuk, W M, Cekala, M, Bøgsted, M, Meristoudis, C, McCulloch, T, Falkmer, U G & Røe, O D 2021, ' Adjuvant platinum-based chemotherapy in non-small cell lung cancer : The role of relative dose-intensity and treatment delay ', Cancer Treatment and Research Communications, vol. 27, 100318 . https://doi.org/10.1016/j.ctarc.2021.100318
Cancer Treatment and Research Communications
BACKGROUND: The study investigated the association of the relative dose-intensity (RDI) of cisplatin and timing of adjuvant platinum-based chemotherapy (APC) with survival for stage I-III non-small cell lung cancer (NSCLC) patients.MATERIAL AND METHO